Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

The euro was trading steadily against the US dollar during the early phase of US trade session, after comments made by Fed President for Philadelphia, Charles Plosser and as political uncertainty in Italy could lead to a decrease in countrys credit rating by Fitch.

EUR/USD touched a session high at 1.3555 at 13:00 GMT, after which consolidation followed at 1.3526, gaining 0.03% for the day. Support was likely to be received at September 25th low, 1.3460, while resistance was to be met at September 27th high, 1.3564.

Earlier on Monday the Fed President for Philadelphia, Charles Plosser, said that the Federal Open Market Committee (FOMC) has undermined confidence in the forward guidance on US monetary policy, after the bank abstained from scaling back its monthly asset purchases at its meeting in September. According to Plosser, this could also cast a doubt upon the statement that the Federal Reserve may tighten its policy, if unemployment rate in the country reaches a specific level. As Fed delayed tapering of its easing program, uncertainty over the future of its policy was increased.

In addition, Fitch Ratings warned that Italys credit rating may be diminished in case of a coalition government collapse, as this, on the other hand, may influence countrys fiscal objectives. The current rating of the country, according to Fitch, is BBB+, which is only three levels above the so called “junk” level.

Meanwhile, in the United States, the Chicago PMI rose to a value of 55.7, reaching its highest point in four months in September, from 53.0 in August. Experts had projected that the index will advance to a reading of 54.0. Values above the key level of 50.0 are usually an indication that business activity has increased. This indicator marked its third consecutive monthly climb, as Septembers result came in consonance with the moderate pace, at which US economy has been recovering. The sub-index of new orders advanced to its highest level since February.

Elsewhere, the euro was losing ground against the pound, with EUR/GBP cross down by 0.13% for the day to trade at 0.8367 at 14:59 GMT.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Forex Market: USD/CAD daily trading forecastForex Market: USD/CAD daily trading forecast Yesterday’s trade saw USD/CAD within the range of 1.2617-1.2769. The pair closed at 1.2686, losing 0.52% on a daily basis.At 9:17 GMT today USD/CAD was up 0.28% for the day to trade at 1.2721. The pair broke the first key weekly resistance […]
  • Euro Area CPI inflation accelerates to 2% in OctoberEuro Area CPI inflation accelerates to 2% in October Annual consumer price inflation in the Euro Area has picked up to 2% in October from 1.7% in September, preliminary data by Eurostat showed.September's rate has been the lowest since April 2021.Market consensus had pointed to a lesser […]
  • Forex Market: EUR/HKD daily forecastForex Market: EUR/HKD daily forecast During yesterday’s trading session EUR/HKD traded within the range of 10.5735-10.6047 and closed at 10.5813.At 7:40 GMT today EUR/HKD was gaining 0.04% for the day to trade at 10.5894. The pair touched a daily high at 10.5895 at 7:41 […]
  • AUD/USD Outlook: UOB Sees Narrow Trading Range For NowAUD/USD Outlook: UOB Sees Narrow Trading Range For Now Key Moments AUD/USD briefly declined to 0.7111 before rebounding to close at 0.7129, a -0.45% move. UOB projects intraday trading to stay within a 0.7110 to 0.7160 range. Over the next one to three weeks, UOB expects […]
  • Novartis AG share price down, acquires a 2.8% stake in Oxford BioMedica as part of a $90-million dealNovartis AG share price down, acquires a 2.8% stake in Oxford BioMedica as part of a $90-million deal Novartis AG shared in an official statement that it managed to strike a deal to acquire a stake in Oxford BioMedica Plc, allowing the Swiss drug manufacturer to work with the U.K.-based gene therapy specialist on a new cancer treatment.The […]
  • Kiwi Firms as RBNZ Holds OCR, Hints at Tightening MoreKiwi Firms as RBNZ Holds OCR, Hints at Tightening More Key Moments NZD/USD traded near 0.5870 during Asian hours as the New Zealand Dollar advanced following the RBNZ decision. The RBNZ kept the Official Cash Rate unchanged at 2.25% at its May policy meeting but indicated further […]